InnovAge (INNV) Competitors $3.45 -0.04 (-1.15%) Closing price 04:00 PM EasternExtended Trading$3.48 +0.03 (+0.87%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock INNV vs. ARDT, PACS, NHC, VRDN, AVAH, TDOC, AHCO, OMDA, GRAL, and PNTGShould you be buying InnovAge stock or one of its competitors? The main competitors of InnovAge include Ardent Health (ARDT), PACS Group (PACS), National HealthCare (NHC), Viridian Therapeutics (VRDN), Aveanna Healthcare (AVAH), Teladoc Health (TDOC), AdaptHealth (AHCO), Omada Health (OMDA), GRAIL (GRAL), and The Pennant Group (PNTG). These companies are all part of the "healthcare" industry. InnovAge vs. Its Competitors Ardent Health PACS Group National HealthCare Viridian Therapeutics Aveanna Healthcare Teladoc Health AdaptHealth Omada Health GRAIL The Pennant Group Ardent Health (NYSE:ARDT) and InnovAge (NASDAQ:INNV) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations. Does the media refer more to ARDT or INNV? In the previous week, InnovAge had 1 more articles in the media than Ardent Health. MarketBeat recorded 4 mentions for InnovAge and 3 mentions for Ardent Health. Ardent Health's average media sentiment score of 0.88 beat InnovAge's score of 0.50 indicating that Ardent Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ardent Health 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InnovAge 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend ARDT or INNV? Ardent Health currently has a consensus price target of $19.56, suggesting a potential upside of 53.29%. InnovAge has a consensus price target of $5.00, suggesting a potential upside of 44.93%. Given Ardent Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Ardent Health is more favorable than InnovAge.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ardent Health 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70InnovAge 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Do institutionals and insiders have more ownership in ARDT or INNV? 12.3% of InnovAge shares are owned by institutional investors. 1.7% of Ardent Health shares are owned by company insiders. Comparatively, 1.4% of InnovAge shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is ARDT or INNV more profitable? Ardent Health has a net margin of 4.11% compared to InnovAge's net margin of -3.75%. Ardent Health's return on equity of 16.66% beat InnovAge's return on equity.Company Net Margins Return on Equity Return on Assets Ardent Health4.11% 16.66% 5.18% InnovAge -3.75%-11.91%-5.85% Which has better valuation & earnings, ARDT or INNV? Ardent Health has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArdent Health$5.97B0.31$210.34M$1.817.05InnovAge$763.85M0.61-$21.34M-$0.23-15.00 SummaryArdent Health beats InnovAge on 12 of the 15 factors compared between the two stocks. Get InnovAge News Delivered to You Automatically Sign up to receive the latest news and ratings for INNV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INNV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INNV vs. The Competition Export to ExcelMetricInnovAgeMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$465.78M$7.66B$5.73B$9.56BDividend YieldN/A2.70%4.53%4.08%P/E Ratio-15.0076.3830.4625.16Price / Sales0.6130.60392.5787.62Price / CashN/A24.2337.0358.50Price / Book1.6916.818.956.21Net Income-$21.34M$243.33M$3.26B$265.38M7 Day Performance-2.27%-0.95%1.06%-1.13%1 Month Performance-9.21%0.99%4.31%-0.71%1 Year Performance-44.98%11.01%28.39%18.86% InnovAge Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INNVInnovAge2.2748 of 5 stars$3.45-1.1%$5.00+44.9%-42.6%$465.78M$763.85M-15.002,350ARDTArdent Health3.1609 of 5 stars$12.64+1.2%$19.56+54.8%-24.9%$1.79B$6.20B6.9824,900PACSPACS Group2.6081 of 5 stars$11.44-0.6%$33.33+191.5%-69.4%$1.75B$3.11B0.0032,433Upcoming EarningsNHCNational HealthCareN/A$107.76+0.2%N/A-13.3%$1.67B$1.46B13.5012,400News CoveragePositive NewsVRDNViridian Therapeutics1.6067 of 5 stars$18.11-2.3%$37.00+104.3%+15.5%$1.51B$300K-4.7350AVAHAveanna Healthcare2.0959 of 5 stars$7.04-0.6%$7.50+6.5%+40.9%$1.48B$2.02B88.0033,500Trending NewsAnalyst UpgradeTDOCTeladoc Health3.2745 of 5 stars$7.48-0.5%$9.76+30.5%+0.2%$1.33B$2.57B-6.295,500Positive NewsAHCOAdaptHealth3.962 of 5 stars$9.38-1.1%$13.40+42.9%-6.6%$1.28B$3.26B17.3710,500Positive NewsOMDAOmada HealthN/A$20.91+1.9%$24.57+17.5%N/A$1.18BN/A0.00849Positive NewsGRALGRAIL1.0919 of 5 stars$32.80+1.1%$31.50-4.0%+100.3%$1.17B$125.60M-2.501,360Insider TradePNTGThe Pennant Group3.6582 of 5 stars$25.11-0.6%$33.40+33.0%-21.5%$873.04M$695.24M32.197,000 Related Companies and Tools Related Companies ARDT Competitors PACS Competitors NHC Competitors VRDN Competitors AVAH Competitors TDOC Competitors AHCO Competitors OMDA Competitors GRAL Competitors PNTG Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INNV) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share InnovAge With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access